Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 18

1.

Subretinal Hyperreflective Material in the Comparison of Age-Related Macular Degeneration Treatments Trials.

Willoughby AS, Ying GS, Toth CA, Maguire MG, Burns RE, Grunwald JE, Daniel E, Jaffe GJ; Comparison of Age-Related Macular Degeneration Treatments Trials Research Group.

Ophthalmology. 2015 Sep;122(9):1846-53.e5. doi: 10.1016/j.ophtha.2015.05.042. Epub 2015 Jul 2.

PMID:
26143666
2.

Metastasis of ciliary body melanoma to the contralateral eye: a case report and review of uveal melanoma literature.

Torossian NM, Wallace RT, Hwu WJ, Bedikian AY.

Case Rep Oncol Med. 2015;2015:427163. doi: 10.1155/2015/427163. Epub 2015 Mar 22.

3.

Outcomes of eyes with lesions composed of >50% blood in the Comparison of Age-related Macular Degeneration Treatments Trials (CATT).

Altaweel MM, Daniel E, Martin DF, Mittra RA, Grunwald JE, Lai MM, Melamud A, Morse LS, Huang J, Ferris FL 3rd, Fine SL, Maguire MG; Comparison of Age-related Macular Degeneration Treatments Trials (CATT) Research Group; Comparison of Age-related Macular Degeneration Treatments Trials CATT Research Group.

Ophthalmology. 2015 Feb;122(2):391-398.e5. doi: 10.1016/j.ophtha.2014.08.020. Epub 2014 Oct 11.

4.

Comparison of optical coherence tomography assessments in the comparison of age-related macular degeneration treatments trials.

Folgar FA, Jaffe GJ, Ying GS, Maguire MG, Toth CA; Comparison of Age-Related Macular Degeneration Treatments Trials Research Group.

Ophthalmology. 2014 Oct;121(10):1956-65. doi: 10.1016/j.ophtha.2014.04.020. Epub 2014 May 15.

5.

Sporadic visual acuity loss in the Comparison of Age-Related Macular Degeneration Treatments Trials (CATT).

Kim BJ, Ying GS, Huang J, Levy NE, Maguire MG; CATT Research Group.

Am J Ophthalmol. 2014 Jul;158(1):128-135.e10. doi: 10.1016/j.ajo.2014.04.004. Epub 2014 Apr 13.

6.

VEGFA and VEGFR2 gene polymorphisms and response to anti-vascular endothelial growth factor therapy: comparison of age-related macular degeneration treatments trials (CATT).

Hagstrom SA, Ying GS, Pauer GJ, Sturgill-Short GM, Huang J, Maguire MG, Martin DF; Comparison of Age-Related Macular Degeneration Treatments Trials (CATT) Research Group.

JAMA Ophthalmol. 2014 May;132(5):521-7.

7.

Macular morphology and visual acuity in the comparison of age-related macular degeneration treatments trials.

Jaffe GJ, Martin DF, Toth CA, Daniel E, Maguire MG, Ying GS, Grunwald JE, Huang J; Comparison of Age-related Macular Degeneration Treatments Trials Research Group.

Ophthalmology. 2013 Sep;120(9):1860-70. doi: 10.1016/j.ophtha.2013.01.073. Epub 2013 May 1.

8.

Pharmacogenetics for genes associated with age-related macular degeneration in the Comparison of AMD Treatments Trials (CATT).

Hagstrom SA, Ying GS, Pauer GJ, Sturgill-Short GM, Huang J, Callanan DG, Kim IK, Klein ML, Maguire MG, Martin DF; Comparison of AMD Treatments Trials Research Group.

Ophthalmology. 2013 Mar;120(3):593-9. doi: 10.1016/j.ophtha.2012.11.037. Epub 2013 Jan 18.

9.

Baseline predictors for one-year visual outcomes with ranibizumab or bevacizumab for neovascular age-related macular degeneration.

Ying GS, Huang J, Maguire MG, Jaffe GJ, Grunwald JE, Toth C, Daniel E, Klein M, Pieramici D, Wells J, Martin DF; Comparison of Age-related Macular Degeneration Treatments Trials Research Group.

Ophthalmology. 2013 Jan;120(1):122-9. doi: 10.1016/j.ophtha.2012.07.042. Epub 2012 Oct 6.

10.

Ranibizumab and bevacizumab for treatment of neovascular age-related macular degeneration: two-year results.

Comparison of Age-related Macular Degeneration Treatments Trials (CATT) Research Group, Martin DF, Maguire MG, Fine SL, Ying GS, Jaffe GJ, Grunwald JE, Toth C, Redford M, Ferris FL 3rd.

Ophthalmology. 2012 Jul;119(7):1388-98. doi: 10.1016/j.ophtha.2012.03.053. Epub 2012 May 1.

11.

Cat scratch disease: posterior segment manifestations.

Solley WA, Martin DF, Newman NJ, King R, Callanan DG, Zacchei T, Wallace RT, Parks DJ, Bridges W, Sternberg P Jr.

Ophthalmology. 1999 Aug;106(8):1546-53.

PMID:
10442903
12.

Symptomatic choroidal neovascularization in blacks.

Capone A Jr, Wallace RT, Meredith TA.

Arch Ophthalmol. 1994 Aug;112(8):1091-7.

PMID:
7519842
13.

Restoration of intraocular pressure after streptococcus endophthalmitis with vitrectomy.

Wallace RT, O'Day DM.

Ophthalmic Surg. 1994 Feb;25(2):110-1.

PMID:
8183507
14.

Branhamella (Moraxella) catarrhalis endophthalmitis.

Bergren RL, Tasman WS, Wallace RT, Katz LJ.

Arch Ophthalmol. 1993 Sep;111(9):1169-70. No abstract available.

PMID:
8363458
15.

The use of perfluorophenanthrene in the removal of intravitreal lens fragments.

Wallace RT, McNamara JA, Brown G, Benson W, Belmont J, Goldberg R, Federman J.

Am J Ophthalmol. 1993 Aug 15;116(2):196-200.

PMID:
8352305
16.

A simple technique for controlled subretinal injections.

Wallace RT, Vander JF.

Retina. 1993;13(3):260-1.

PMID:
7694346
17.

Sudden retinal manifestations of intranasal cocaine and methamphetamine abuse.

Wallace RT, Brown GC, Benson W, Sivalingham A.

Am J Ophthalmol. 1992 Aug 15;114(2):158-60.

PMID:
1642290
18.

Leukemic infiltration of the optic nerve.

Wallace RT, Shields JA, Shields CL, Ehya H, Ewing M.

Arch Ophthalmol. 1991 Jul;109(7):1027. No abstract available.

PMID:
2064557
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk